Literature DB >> 5133438

EEG profiles of fenfluramine, amobarbital and dextroamphetamine in normal volunteers.

M Fink, D M Shapiro, T M Itil.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5133438     DOI： 10.1007/BF00406875

Source DB:  PubMed          Journal:  Psychopharmacologia


× No keyword cloud information.
  18 in total

1.  ELECTROENCEPHALOGRAPHIC MANIFESTATIONS ASSOCIATED WITH PSYCHOTIC ILLNESS: PENTOTHAL ACTIVATION TECHNIQUE AND PHARMACOLOGIC INTERRELATIONSHIPS.

Authors:  D GOLDMAN
Journal:  Compr Psychiatry       Date:  1964-04       Impact factor: 3.735

2.  A neurophysiological test for psychiatric diagnosis: results in 750 patients.

Authors:  C SHAGASS; A L JONES
Journal:  Am J Psychiatry       Date:  1958-05       Impact factor: 18.112

3.  The effect of acute administration of (meta trifluoro methyl-phenyl)-1-(benzoyl oxy) ethyl amino-2-propane (780 SE) and fenfluramine on human sleep.

Authors:  H Firth; S A Lewis; O O Ogunremi; I Oswald
Journal:  Br J Pharmacol       Date:  1970-06       Impact factor: 8.739

4.  Fenfluramine and critical flicker frequency.

Authors:  R C Hill; P Turner
Journal:  J Pharm Pharmacol       Date:  1967-05       Impact factor: 3.765

Review 5.  EEG and human psychopharmacology.

Authors:  M Fink
Journal:  Annu Rev Pharmacol       Date:  1969       Impact factor: 13.820

6.  Comparison of fenfluramine and metformin in treatment of obesity.

Authors:  A A Lawson; J A Strong; P Peattie; P Roscoe; A Gibson
Journal:  Lancet       Date:  1970-08-29       Impact factor: 79.321

7.  Effects of two slimming drugs on sleep.

Authors:  I Oswald; H S Jones; J E Mannerheim
Journal:  Br Med J       Date:  1968-03-30

8.  A double-blind clinical trial of an appetite depressant, fenfluramine, in general practice.

Authors:  P Brodbin; C A O'Connor
Journal:  Practitioner       Date:  1967-05

9.  Clinical and EEG studies of doxepin. An interim report.

Authors:  J Simeon; M Spero; M Fink
Journal:  Psychosomatics       Date:  1969 May-Jun       Impact factor: 2.386

10.  Fenfluramine (Ponderax) in the treatment of obese psychiatric out-patients.

Authors:  R Gaind
Journal:  Br J Psychiatry       Date:  1969-08       Impact factor: 9.319
View more
  6 in total

1.  Localization of MDMA-induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA).

Authors:  E Frei; A Gamma; R Pascual-Marqui; D Lehmann; D Hell; F X Vollenweider
Journal:  Hum Brain Mapp       Date:  2001-11       Impact factor: 5.038

2.  Fenfluramine stimulation of serum cortisol in patients with major affective disorders and healthy controls: further evidence for a central serotonergic action of lithium in man.

Authors:  H D Mühlbauer; B Müller-Oerlinghausen
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

3.  The effects of dexamphetamine on the resting-state electroencephalogram and functional connectivity.

Authors:  Matthew A Albrecht; Gareth Roberts; Greg Price; Joseph Lee; Rajan Iyyalol; Mathew T Martin-Iverson
Journal:  Hum Brain Mapp       Date:  2015-11-18       Impact factor: 5.038

Review 4.  Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

5.  Effect of dexfenfluramine on sleep in healthy subjects.

Authors:  M Wiegand; S Bossert; R Kinney; K M Pirke; J C Krieg
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 6.  Appetite suppressants. A review.

Authors:  T Silverstone
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.